Jia-hai Lee

Array ( [id] => 8417579 [patent_doc_number] => 20120245079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-27 [patent_title] => 'Treatment of Diseases Caused by Bacterial Exotoxins' [patent_app_type] => utility [patent_app_number] => 13/393603 [patent_app_country] => US [patent_app_date] => 2010-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 25418 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13393603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8430854 [patent_doc_number] => 20120252730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'PLATELET AGGREGATION INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/393608 [patent_app_country] => US [patent_app_date] => 2010-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10729 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13393608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8290366 [patent_doc_number] => 20120178693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'Cofactors for Thrombin Activation of Factor VII and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 13/393157 [patent_app_country] => US [patent_app_date] => 2010-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10771 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13393157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8465644 [patent_doc_number] => 20120270812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'COMPOSITIONS, METHODS, AND KITS FOR DETERMINING AN ALKYL TRANSFERASE' [patent_app_type] => utility [patent_app_number] => 13/381677 [patent_app_country] => US [patent_app_date] => 2010-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19153 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13381677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9273536 [patent_doc_number] => 08637468 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-28 [patent_title] => 'Synthetic cholesterylamine-linker derivatives for agent delivery into cells' [patent_app_type] => utility [patent_app_number] => 13/390327 [patent_app_country] => US [patent_app_date] => 2010-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 29 [patent_no_of_words] => 18600 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13390327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8253057 [patent_doc_number] => 20120157379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'Gastric Inhibitory Peptide Variants and Their Uses' [patent_app_type] => utility [patent_app_number] => 13/387931 [patent_app_country] => US [patent_app_date] => 2010-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 22201 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20120157379.pdf [firstpage_image] =>[orig_patent_app_number] => 13387931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8441487 [patent_doc_number] => 20120258104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-11 [patent_title] => 'Delivery System and Conjugates For Compound Delivery Via Naturally Occurring Intracellular Transport Routes' [patent_app_type] => utility [patent_app_number] => 13/386347 [patent_app_country] => US [patent_app_date] => 2010-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 62133 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13386347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9843640 [patent_doc_number] => 08945551 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-03 [patent_title] => 'Biopolymer hybrid gel-depot delivery system' [patent_app_type] => utility [patent_app_number] => 13/382655 [patent_app_country] => US [patent_app_date] => 2010-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 44 [patent_no_of_words] => 11214 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13382655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9823529 [patent_doc_number] => 08933013 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-13 [patent_title] => 'Co-administration of an agent linked to an internalization peptide with an anti-inflammatory' [patent_app_type] => utility [patent_app_number] => 13/377519 [patent_app_country] => US [patent_app_date] => 2010-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 16 [patent_no_of_words] => 25978 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13377519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8477759 [patent_doc_number] => 20120277165 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'METHODS OF MODULATING FUCOSYLATION OF GLYCOPROTEINS' [patent_app_type] => utility [patent_app_number] => 13/375577 [patent_app_country] => US [patent_app_date] => 2010-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 38088 [patent_no_of_claims] => 324 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13375577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13049121 [patent_doc_number] => 10045937 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-08-14 [patent_title] => Therapeutic agent delivery system and method [patent_app_type] => utility [patent_app_number] => 13/376298 [patent_app_country] => US [patent_app_date] => 2010-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 16572 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13376298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8567139 [patent_doc_number] => 20120329709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-27 [patent_title] => 'PRODUCTION OF GLYCOPROTEINS' [patent_app_type] => utility [patent_app_number] => 13/322049 [patent_app_country] => US [patent_app_date] => 2010-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 22188 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13322049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11843326 [patent_doc_number] => 09730865 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-15 [patent_title] => 'Application and uses of PRG4 and therapeutic modulation thereof' [patent_app_type] => utility [patent_app_number] => 13/321532 [patent_app_country] => US [patent_app_date] => 2010-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13019 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13321532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9216440 [patent_doc_number] => 08629240 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-14 [patent_title] => 'Peptide ligands for clusterin and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/260676 [patent_app_country] => US [patent_app_date] => 2010-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 19 [patent_no_of_words] => 9589 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13260676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10191856 [patent_doc_number] => 09220750 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-29 [patent_title] => 'Use of antisecretory factors (AF) for optimizing cellular uptake' [patent_app_type] => utility [patent_app_number] => 13/148878 [patent_app_country] => US [patent_app_date] => 2010-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15478 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13148878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199275 [patent_doc_number] => 20120122776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'DPP-IV INHIBITORS FOR TREATMENT OF DIABETES IN PEDIATRIC PATIENTS' [patent_app_type] => utility [patent_app_number] => 13/145857 [patent_app_country] => US [patent_app_date] => 2010-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13568 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122776.pdf [firstpage_image] =>[orig_patent_app_number] => 13145857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8807985 [patent_doc_number] => 08445637 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-21 [patent_title] => 'SPARC binding peptides and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/132274 [patent_app_country] => US [patent_app_date] => 2009-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 15598 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13132274 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7650898 [patent_doc_number] => 20110300167 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'CXCR5 RECEPTOR COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/127666 [patent_app_country] => US [patent_app_date] => 2009-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 20781 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20110300167.pdf [firstpage_image] =>[orig_patent_app_number] => 13127666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10057302 [patent_doc_number] => 09096646 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-04 [patent_title] => 'CXCR4 receptor compounds' [patent_app_type] => utility [patent_app_number] => 13/127443 [patent_app_country] => US [patent_app_date] => 2009-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 50 [patent_no_of_words] => 34277 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13127443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5973590 [patent_doc_number] => 20110152500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'Bipodal-Peptide Binder' [patent_app_type] => utility [patent_app_number] => 12/999717 [patent_app_country] => US [patent_app_date] => 2009-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 14582 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152500.pdf [firstpage_image] =>[orig_patent_app_number] => 12999717 [rel_patent_id] =>[rel_patent_doc_number] =>)